CIGNA Announces Appearance at the UBS 21st Annual Global Healthcare Services Conference

PHILADELPHIA--(BUSINESS WIRE)-- CIGNA Corporation (NYSE: CI) announced today that Tom McCarthy, Acting Chief Financial Officer, will be presenting at the UBS 21st Annual Global Healthcare Services Conference on February 7, 2011 in New York, NY.

CIGNA's presentation is expected to begin at approximately 11:00 a.m. Eastern Time. Investors, analysts, and the general public are invited to listen to the presentation free over the Internet via webcast by visiting http://www.cigna.com and clicking on Investors, then the Event Calendar link.

To listen to this presentation live on the Internet, visit http://www.cigna.com at least 15 minutes prior to the presentation (to download and install any necessary audio software).

CIGNA Corporation is a global health service company dedicated to helping people improve their health, well-being and sense of security. CIGNA’s operating subsidiaries provide health and related benefits to customers throughout the United States and around the world, including health care products and services, life, accident and disability insurance, and expatriate benefits. As of December 31, 2010, CIGNA Corp. and its subsidiaries had shareholders' equity of $6.6 billion. Full year 2010 revenues totaled $21.3 billion. To learn more about CIGNA, visit http://www.cigna.com.



CONTACT:

CIGNA Corporation
Ted Detrick, Investor Relations, +1-215-761-1414

KEYWORDS:   United States  North America  New York  Pennsylvania

INDUSTRY KEYWORDS:   Practice Management  Health  Hospitals  Other Health  Professional Services  Insurance  General Health  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options. 

Centene announced another five states have approved its pending $17B merger with WellCare, bringing total number of approvals to 24.